4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-21-001545
Director sold 52,500 shares at an average $11.92 ($625,775)
- Director acquired 52,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BLOCK STEPHEN A · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 1 in the form | +32,500 | $1.92 | $62,400 | 49,167 | D |
| 2021-03-15 | Sale : show line 2 in the form | −32,500 | $11.15 | $362,375 | 16,667 | D |
| 2021-03-16 | Exercise or conversion : show line 3 in the form | +20,000 | $2.61 | $52,100 | 36,667 | D |
| 2021-03-16 | Sale : show line 4 in the form | −20,000 | $13.17 | $263,400 | 16,667 | D |
| Open-market sales · 52,500 sh · avg $11.92 · $625,775 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 5 in the form Stock Options (right to buy) | −32,500 | 0 | D |
| 2021-03-16 | Exercise or conversion : show line 6 in the form Stock Options (right to buy) | −20,000 | 0 | D |
Loading xslF345X03/form4-03172021_030350.xml…